Nitric oxide and COVID-19: Dose, timing and how to administer it might be crucial
- PMID: 33533477
- PMCID: PMC8013843
- DOI: 10.1111/aas.13788
Nitric oxide and COVID-19: Dose, timing and how to administer it might be crucial
Keywords: COVID-19; acute lung injury; mechanical ventilation; nitric oxide; oxygenation; pulmonary vasoconstriction.
Conflict of interest statement
The author CF wishes to report financial interest in the development of a new intravenous NO‐donor. The author GH has no conflict of interest to declare.
Comment on
-
Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile?Acta Anaesthesiol Scand. 2021 May;65(5):629-632. doi: 10.1111/aas.13757. Epub 2020 Dec 20. Acta Anaesthesiol Scand. 2021. PMID: 33296498
References
-
- Adhikari NKJ, Dellinger RP, Lundin S, et al. Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity systematic review and meta‐analysis*. Crit Care Med. 2014;42(2):404‐412. - PubMed
-
- Gerlach H, Rossaint R, Pappert D, et al. Time‐course and dose‐response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest. 1993;23(8):499‐502. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
